Quelling Public Fears About Guillain-Barré Syndrome and COVID-19 Vaccination

Affiliations

¹ From the Department of Neurology (D.B.), Oregon Health & Science University, Portland; and Amsterdam UMC (J.K.), Vrije Universiteit Amsterdam, Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, the Netherlands.
² From the Department of Neurology (D.B.), Oregon Health & Science University, Portland; and Amsterdam UMC (J.K.), Vrije Universiteit Amsterdam, Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, the Netherlands. j.killestein@amsterdamumc.nl.

Editorial

Dennis Bourdette et al. Neurology. 2021.

. 2021 May 31;96(22):1021-1022.

doi: 10.1212/WNL.0000000000011882.

¹ From the Department of Neurology (D.B.), Oregon Health & Science University, Portland; and Amsterdam UMC (J.K.), Vrije Universiteit Amsterdam, Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, the Netherlands.
² From the Department of Neurology (D.B.), Oregon Health & Science University, Portland; and Amsterdam UMC (J.K.), Vrije Universiteit Amsterdam, Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, the Netherlands. j.killestein@amsterdamumc.nl.

No abstract available

Comment in

Guillain-Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial: Temporal Associations Do Not Imply Causality.
Márquez Loza AM, Holroyd KB, Johnson SA, Pilgrim DM, Amato AA. Márquez Loza AM, et al. Neurology. 2021 May 31;96(22):1052-1054. doi: 10.1212/WNL.0000000000011881. Neurology. 2021. PMID: 33824169 No abstract available.

Guillain-Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial: Temporal Associations Do Not Imply Causality.
Márquez Loza AM, Holroyd KB, Johnson SA, Pilgrim DM, Amato AA. Márquez Loza AM, et al. Neurology. 2021 May 31;96(22):1052-1054. doi: 10.1212/WNL.0000000000011881. Neurology. 2021. PMID: 33824169 No abstract available.